...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - a new age for confirmatory tests in SLE diagnostics.
【24h】

Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - a new age for confirmatory tests in SLE diagnostics.

机译:间接免疫荧光技术可标准化检测抗ds DNA抗体-SLE诊断学中验证性测试的新时代。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We read with great interest the well conducted comparative study of different techniques for the detection of antibodies to double-stranded (ds) DNA by Chiaro et al. in this journal recently [1]. The authors concluded that the Crithidia luciliae immunofluorescence test (CLIFT) is still a relevant confirmatory tool comparing it with 6 different enzyme immunoassays (EIAs). However, their data demonstrated significant differences in the analytical concordance between ELISAs for detecting anti-dsDNA IgG antibodies and the CLIFT confirmatory with implications for interlaboratory testing. Until recently, a moderate sensitivity of anti-dsDNA antibody detection by CLIFT was usually reported regarding the diagnosis of systemic lupus erythematosus (SLE) [2]. An improved sensitivity of anti-dsDNA IgG results by a novel CLIFT employing the kinetoplast DNA of the hemoflagellate C. luciliae as a solid-phase autoantigen with a changed reaction environment was reported by our group recently [3,4]. As a fact, this modified CLIFT showed an increased sensitivity of 76.4% with a high specificity of 99% characteristic for commercial CLIFT assays in general. The novel CLIFT was characterized by a better correlation with Farr assay rather than with ELISA results. Thus, the relatively low specificity of just 84% for the CLIFT assay reported by Chiaro et al. in their study is remarkably surprising. It is well accepted that CLIFT anti-dsDNA results are highly appreciated by clinicians due to the unsurpassed high specificity of this parameter in particular for clinical complications like lupus nephritis. Antibodies against dsDNA are known to be highly heterogeneous with respect to their epitope specificity, avidity, immunoglobulin subclass composition, and complement-fixing avidity. However, the real autoantigenic target structure for anti-dsDNA IgG antibodies in patients with SLE has not been identified yet and consequently the diagnostic performance of anti-dsDNA antibody testing varies ...
机译:我们非常感兴趣地阅读了Chiaro等人对用于检测双链(ds)DNA抗体的不同技术进行的比较良好的比较研究。最近在这本杂志上[1]。作者得出的结论是,与6种不同的酶免疫测定法(EIA)相比,Crithidia luciliae免疫荧光测试(CLIFT)仍然是一种相关的确认工具。但是,他们的数据表明,用于检测抗dsDNA IgG抗体的ELISA与CLIFT确证方法之间在分析一致性方面存在显着差异,这对实验室间测试具有重要意义。直到最近,关于系统性红斑狼疮(SLE)的诊断,通常通过CLIFT检测抗dsDNA抗体的敏感性中等[2]。最近,我们小组报道了一种新的CLIFT技术,提高了抗dsDNA IgG的敏感性,该技术将鞭毛衣藻的动质体DNA用作固相自体抗原,反应环境发生了变化[3,4]。实际上,这种修饰的CLIFT对商业CLIFT分析通常显示出增加的76.4%的灵敏度和99%的高特异性。新型CLIFT的特点是与Farr分析相比具有更好的相关性,而不是与ELISA结果相关。因此,Chiaro等人报道的CLIFT分析的特异性相对较低,仅为84%。在他们的研究中非常令人惊讶。由于该参数的超高特异性,特别是对于诸如狼疮性肾炎这样的临床并发症,临床医生高度赞赏CLIFT抗dsDNA结果。就其表位特异性,亲和力,免疫球蛋白亚类组成和补体固定亲和力而言,已知针对dsDNA的抗体高度异质。但是,尚未确定SLE患者抗dsDNA IgG抗体的真正自身抗原靶结构,因此抗dsDNA抗体检测的诊断性能有所不同...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号